Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/10/2025

Management of Borderline Hypercholesterolemia

Risk Assessment and Initial Approach

  • Patients with mildly elevated LDL-C and low overall cardiovascular risk, such as those with a 10-year cardiovascular risk <10%, are considered lower risk, as suggested by the American Heart Association guidelines 1, 2

Therapeutic Lifestyle Changes

  • The initial approach for patients with mildly elevated LDL-C and low overall cardiovascular risk should be therapeutic lifestyle changes for 3-6 months, including dietary modifications (reducing saturated fat to <7% of total calories, limiting dietary cholesterol to <200 mg/day, and increasing viscous fiber to 10-25 g/day) and weight management (targeting 5-10% weight reduction and BMI <25 kg/m²) 1, 3, 4
  • Physical activity should include 150-300 minutes of moderate-intensity exercise weekly, with both aerobic exercise and resistance training (at least 2 days/week), as recommended by the American Heart Association 5, 6, 7, 1
  • Increasing omega-3 fatty acids through fish or supplements (1g/day) and adding plant stanols/sterols (2 g/day) can help lower triglycerides and cholesterol levels, as suggested by the American College of Cardiology and 8, 6

Pharmacotherapy

  • If lifestyle modifications fail to adequately lower LDL-C after 3-6 months, statin therapy may be indicated for patients with 0-1 risk factors and LDL-C remaining ≥160 mg/dL, with a target of at least 30-40% reduction in LDL-C, as recommended by the American College of Cardiology and 9, 1, 2
  • High-intensity statin therapy (atorvastatin 40-80 mg or rosuvastatin 20-40 mg daily) is recommended as first-line therapy, aiming for a 30-40% reduction in LDL cholesterol, as recommended by 10, 9
  • For persistently low HDL despite statin therapy, niacin may be beneficial, and fibrates (fenofibrate preferred over gemfibrozil) can be considered, as suggested by the American College of Cardiology and 9, 11
  • For elevated triglycerides despite statin therapy, fibrate therapy should be added to prevent pancreatitis if triglycerides >500 mg/dL, and intensify LDL-lowering therapy and consider adding niacin or fibrates if triglycerides are 200-499 mg/dL, as recommended by the American Heart Association and the American College of Cardiology 7, 8

Follow-up and Monitoring

  • Reassess lipid profile in 3-6 months after initiating lifestyle changes, and if started on statin, check lipid profile and liver function tests after 4-6 weeks, as recommended by 5, 6, 1
  • Once stable, monitor lipid profile annually, and consider ezetimibe, bile acid sequestrants, or PCSK9 inhibitors for statin intolerance, as recommended by 5, 12
  • Medication adherence is critical for efficacy, and addressing potential barriers and side effects is essential, as recommended by 6
Dietary Component Recommended Intake
Saturated fat <7% of total calories
Dietary cholesterol <200 mg/day
Viscous fiber 10-25 g/day
Omega-3 fatty acids 1g/day
Plant stanols/sterols 2 g/day
Simple sugar intake Reduced

REFERENCES

6

Managing Elevated LDL Cholesterol [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025